BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24706428)

  • 21. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
    Kirbas A; Kirbas S; Cure MC; Tufekci A
    J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between serum visfatin level and children and adolescent obesity and non-alcoholic fatty liver disease].
    Wen H; Wang HJ; Dong B; Ma J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):269-72. PubMed ID: 22613376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
    Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
    Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum paraoxonase, arylesterase activities and oxidative status in patients with insomnia.
    Liang B; Li YH; Kong H
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2517-22. PubMed ID: 24089233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S; Aslan M; Horoz M; Gur M; Erel O
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.
    Köroğlu E; Canbakan B; Atay K; Hatemi İ; Tuncer M; Dobrucalı A; Sonsuz A; Gültepe I; Şentürk H
    Turk J Gastroenterol; 2016 Jul; 27(4):361-6. PubMed ID: 27458852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease.
    Pirgon O; Bilgin H; Tolu I; Odabas D
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):189-95. PubMed ID: 21521307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease.
    Ustyol A; Aycan Ustyol E; Gurdol F; Kokali F; Bekpınar S
    Scand J Clin Lab Invest; 2017 May; 77(3):205-209. PubMed ID: 28318371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease.
    Pampanini V; Inzaghi E; Germani D; Alterio A; Puglianiello A; Alisi A; Nobili V; Cianfarani S
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):71-76. PubMed ID: 29122442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.
    Krzystek-Korpacka M; Patryn E; Hotowy K; Czapińska E; Majda J; Kustrzeba-Wójcicka I; Noczyńska A; Gamian A
    Adv Clin Exp Med; 2013; 22(2):229-36. PubMed ID: 23709379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease.
    Torun E; Özgen IT; Gökçe S; Aydın S; Cesur Y
    J Clin Res Pediatr Endocrinol; 2014; 6(1):34-9. PubMed ID: 24637308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory cytokines and non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents.
    Assunção SNF; Sorte NCAB; Alves CAD; Mendes PSA; Alves CRB; Silva LR
    Nutr Hosp; 2018 Jan; 35(1):78-83. PubMed ID: 29565153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum oxidative stress parameters and paraoxonase-1 in children and adolescents exposed to passive smoking.
    Kahraman FU; Torun E; Osmanoğlu NK; Oruçlu S; Özer ÖF
    Pediatr Int; 2017 Jan; 59(1):68-73. PubMed ID: 27337344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity.
    Kim JY; Cho J; Yang HR
    J Korean Med Sci; 2018 Apr; 33(16):e122. PubMed ID: 29651819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children.
    Flisiak-Jackiewicz M; Bobrus-Chociej A; Tarasów E; Wojtkowska M; Białokoz-Kalinowska I; Lebensztejn DM
    Can J Gastroenterol Hepatol; 2018; 2018():3870454. PubMed ID: 29854715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease.
    Angın Y; Arslan N; Kuralay F
    Turk J Pediatr; 2014; 56(3):259-66. PubMed ID: 25341597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum paraoxonase activity and oxidative status in subjects with alopecia areata.
    Bilgili SG; Ozkol H; Karadag AS; Ozkol HU; Seker A; Calka O; Aslan M
    Cutan Ocul Toxicol; 2013 Oct; 32(4):290-3. PubMed ID: 23590718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between Neck Circumference and Non-Alcoholic Fatty Liver Disease in Childhood Obesity.
    Hatipoğlu N; Doğan S; Mazıcıoğlu MM; Kurtoğlu S
    J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):32-9. PubMed ID: 26758497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents].
    Clemente AP; Netto BD; de Carvalho-Ferreira JP; da Silveira Campos RM; de Piano Ganen A; Tock L; de Mello MT; Dâmaso AR
    Rev Paul Pediatr; 2016; 34(1):47-55. PubMed ID: 26830602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.